The behavioural pharmacology of dementia
Announcement of 2018 Special Issue : Behavioural pharmacology and brain–body signalling processes
The contribution of transgenic and nontransgenic animal models in Alzheimer’s disease drug research and development
A second wind for the cholinergic system in Alzheimer’s therapy
Behavioural effects of novel multitarget anticholinesterasic derivatives in Alzheimer’s disease
Neural activity, memory, and dementias : serotonergic markers
The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer’s disease
Alzheimer’s disease pathology and the unfolded protein response : prospective pathways and therapeutic targets
Alzheimer’s disease in the zebrafish : where can we take it?
Pharmacological activation of protein kinase A improves memory loss and neuropathological changes in a mouse model of dementia of Alzheimer’s type
A preclinical screen to evaluate pharmacotherapies for the treatment of agitation in dementia
Oral administration of grape seed polyphenol extract restores memory deficits in chronic cerebral hypoperfusion rats
Neuroprotective effects of pretreatment with minocycline on memory impairment following cerebral ischemia in rats
Neuroinflammatory response to experimental stroke is inhibited by boldine
Downregulation of circulating insulin-like growth factor 1 contributes to memory impairment in aged mice after sevoflurane anesthesia